A Study of GC012F Injection in Subjects with Refractory Systemic Lupus Erythematosus

Trial Identifier:	D8313C00002
Sponsor:	Gracell Biotechnologies (Shanghai) Co., Ltd.
Collaborator:	Astrazeneca Suzhou Gracell Biotechnologies Co., Ltd.
Start Date:	August 2024
Primary Completion Date:	February 2027
Study Completion Date:	February 2027

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
CN	Shanghai, CN
CN	Wuhan, CN, 430060

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.